Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC17 for Intraoperative Imaging of Pulmonary Adenocarcinoma
NCT02653612Phase 1Withdrawn
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of EC-17 in lung adenocarcinoma, sponsored by VA Office of Research & Development. Primary endpoints: Intraoperative margin assessment and Intraoperative lymph node assessment at 4 hours. Planned start Jan 2016; status: withdrawn.
02
Drugs
EC-17
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT02653612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653612.